1.780USD-3.26%Mkt Cap: 123.87M $P/E: —1d ago
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap123.87M $
Enterprise Value204.01M $
Revenue (TTM)151.64M $
Gross Profit72.31M $
Net Income (TTM)-39.00M $
Revenue/Share2.231 USD
Last Price1.780 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees658
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.29
PEG—
EV/EBITDA-7.91
EV/Revenue1.35
P/S0.82
P/B9.32
EPS (TTM)-0.54
EPS (Forward)-0.34
52W Range
0.800024% of range4.850
52W High4.850 USD
52W Low0.8000 USD
Profitability
Gross Margin48.48%
Oper. Margin-26.11%
EBITDA Margin-17.00%
Profit Margin-26.15%
ROE-174.27%
ROA-27.55%
Growth
Revenue Growth7.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.37M $
CapEx (TTM)801.00K $
FCF Margin-3.02%
FCF Yield-3.70%
Net Debt72.17M $
Net Debt/EBITDA-2.80
Balance Sheet
Debt/Equity4.04
Current Ratio1.67
Quick Ratio1.03
Book Value/Sh0.1910 USD
Cash/Share0.1900 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.333 USD
Upside (mean)+143.4%
Target Range3.000 USD – 7.000 USD
$3.000+143.4% to mean$7.000
# Analysts3
Ownership
Shares Out.69.59M
Float28.38M
Insiders33.04%
Institutions59.77%
Short Interest
Short Ratio5.2d
Short % Float22.36%
Short % Out.11.04%
Shares Short7.68M
Short (prev mo.)9.88M
Technical
SMA 501.436 (+24.0%)
SMA 2001.726 (+3.2%)
Beta1.06
S&P 52W Chg20.25%
Avg Vol (30d)1.69M
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)66.9
MACD0.1185
MACD Signal0.0661
MACD Hist.+0.0525
BB Upper1.923 USD
BB Middle1.453 USD
BB Lower0.9833 USD
BB Width64.65%
ATR (14)0.1848 USD
Vol Ratio (20d)8.22x